|
| ID |
DDInter1027 |
| Drug Type |
small molecule |
| Molecular Formula |
C19H18F3N3O2 |
| Molecular Weight |
377.366
|
| Description |
Lasmiditan is an oral 5HT1F agonist used for the acute treatment of migraine headache with or without aura.
|
| ATC Classification |
- |
| IUPAC Name |
2,4,6-Trifluoro-N-[6-(1-Methylpiperidine-4-Carbonyl)Pyridin-2-Yl]Benzamide |
| InChI |
Inchi=1S/C19H18F3N3O2/C1-25-7-5-11(6-8-25)18(26)15-3-2-4-16(23-15)24-19(27)17-13(21)9-12(20)10-14(17)22/H2-4,9-11H,5-8H2,1H3,(H,23,24,27) |
| InChI Key |
XEDHVZKDSYZQBF-UHFFFAOYSA-N |
| Canonical SMILES |
CN1CCC(CC1)C(=O)C1=CC=CC(NC(=O)C2=C(F)C=C(F)C=C2F)=N1 |
| Useful Links |
DrugBank
ChEMBL
PubChem
|